Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Merida Biosciences

Request full access

Precision immunology leader developing targeted therapies for autoimmune and allergic disorders

Cambridge, United StatesFounded 2022Biotech & Life Sciences

About Merida Biosciences

Merida Biosciences operates in the biopharmaceutical sector, focusing on precision immunology to address autoimmune and allergic disorders. The company aims to develop highly specific therapies that provide greater relief for patients, distinguishing itself from current treatments that are often non-specific and come with significant side effects. Merida's business model revolves around the discovery and development of these targeted therapies, serving patients suffering from autoimmune and allergic conditions. The company generates revenue through the commercialization of its therapies, leveraging the extensive experience of its leadership team in global biopharmaceutical operations and corporate development. Merida's market includes healthcare providers and patients seeking more effective and safer treatment options for autoimmune and allergic diseases. The leadership team, with a strong background in commercial operations and drug development, is well-positioned to drive the company's growth and achieve its vision of becoming a leader in precision immunology.

Source: Dealroom company data

At a glance

Status
Operational
Employees
63
Open positions
10
Dealroom signal
60.5/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Precision Medicine, Immunotherapy, Biotech and Pharma, DT and LS
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Apr 2025 $121M $484M GV · Third Rock Ventures · BVF Partners · Bain Capital Life Sciences ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Merida Biosciences website traffic

Latest recorded traffic for Merida Biosciences is 5.8K monthly website visits, down 15.9% over the last three months.

Latest monthly visits5.8K 3-month web change-15.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Merida Biosciences in the Cambridge ecosystem

Live from Dealroom

The Merida Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Merida Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.